These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20352464)

  • 1. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
    Maeda T; Kikuchi E; Matsumoto K; Yazawa S; Hagiuda J; Miyajima A; Nakagawa K; Fujiwara H; Hoshino H; Oya M
    Int J Clin Oncol; 2010 Oct; 15(5):508-11. PubMed ID: 20352464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Chang Y; Mbeo G; Littman SJ
    J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
    Han CH; Findlay MP
    Intern Med J; 2010 Feb; 40(2):153-9. PubMed ID: 20446957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
    Ryan SA; Maceneaney P; O'Reilly SP; Moylan EJ; Power DG
    Med Oncol; 2012 Jun; 29(2):1287-91. PubMed ID: 21390516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.
    Rajasekhar A; George TJ
    Oncologist; 2007 Nov; 12(11):1332-5. PubMed ID: 18055853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.
    Wang W; Zhao LR; Lin XQ; Feng F
    World J Gastroenterol; 2014 Jun; 20(21):6691-7. PubMed ID: 24914397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.
    Iwasaki K; Obara W; Kato Y; Takata R; Tanji S; Fujioka T
    Jpn J Clin Oncol; 2013 Feb; 43(2):193-9. PubMed ID: 23275643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.
    Matsubara N; Mukai H; Naito Y; Nezu M; Itoh K
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):310-7. PubMed ID: 23127231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
    Chen YH; Huang CH
    Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer].
    Matsumura E; Ashikari A; Tasaki S; Haranaga S; Toyosato T; Ashimine S; Machida N; Oshiro Y; Saito S
    Hinyokika Kiyo; 2011 Feb; 57(2):81-5. PubMed ID: 21412040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
    Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
    Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder.
    Scosyrev E; Messing EM; van Wijngaarden E; Peterson DR; Sahasrabudhe D; Golijanin D; Fisher SG
    Cancer; 2012 Jan; 118(1):72-81. PubMed ID: 21720989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of reversible posterior leukoencephalopathy syndrome(RPLS)induced by modified FOLFOX6].
    Matsunaga M; Miwa K; Araki K; Sunakawa Y; Yamashita K; Kaneta T; Nakayama H; Noguchi T; Nagashima F; Sasaki Y
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1283-6. PubMed ID: 22902460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
    Gunaratne DA; Krieger LE; Maclean F; Vaux KJ; Chalasani V
    Clin Genitourin Cancer; 2016 Feb; 14(1):e103-5. PubMed ID: 26431887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral vasculitis associated with gemcitabine].
    Schmorl P; Heer-Sonderhoff A; Vosshenrich R; Conrad S
    Urologe A; 2010 Feb; 49(2):268-70. PubMed ID: 20213928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible posterior leukoencephalopathy syndrome after carboplatin and paclitaxel regimen for lung cancer.
    Imai H; Okuno N; Ishihara S; Nakano S; Higuchi S; Arai T; Tokunaga M; Kobayashi H; Arai T; Mori M
    Intern Med; 2012; 51(8):911-5. PubMed ID: 22504249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
    Onujiogu N; Lengyel E; Yamada SD
    Gynecol Oncol; 2008 Dec; 111(3):537-9. PubMed ID: 18554701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer.
    Meleis L; Moore R; Inman BA; Harrison MR
    J Oncol Pharm Pract; 2020 Mar; 26(2):330-337. PubMed ID: 31081469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of neoadjuvant chemotherapy using gemcitabine and cisplatin in muscle invasive bladder cancer: A retrospective analysis of the patient and treatment factors in a single institute.
    Lee KCE; Mui WH; Chan W; Wong CSF; Chu SKP
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1170. PubMed ID: 32721111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy].
    Shirato A; Shimamoto K; Ozawa A; Tanji N; Yokoyama M
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2097-9. PubMed ID: 17197762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.